Home › Compare › PAEGF vs MRK

PAEGF vs MRK: Dividend Comparison 2026

PAEGF yields 200000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAEGF wins by $4.911780474428384e+29M in total portfolio value
10 years
PAEGF
PAEGF
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full PAEGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PAEGF vs MRK

📍 PAEGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPAEGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PAEGF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PAEGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAEGF
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PAEGF beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAEGF + MRK for your $10,000?

PAEGF: 50%MRK: 50%
100% MRK50/50100% PAEGF
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PAEGF
No analyst data
Altman Z
1.6
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAEGF buys
0
MRK buys
0
No recent congressional trades found for PAEGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPAEGFMRK
Forward yield200000.00% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$4.911780474428384e+29M$56.8K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$4.911464459982279e+29M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PAEGF vs MRK ($10,000, DRIP)

YearPAEGF PortfolioPAEGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,206$366.19+$20.00M → PAEGF
2$37,424,589,019$37,403,177,570.09$12,650$502.35+$37424.58M → PAEGF
3$65,416,215,188,220$65,376,170,877,969.18$14,407$694.19+$65416215.17M → PAEGF
4$106,868,230,495,008,900$106,798,235,144,757,520.00$16,585$967.82+$106868230494.99M → PAEGF
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$19,342$1,363.89+$163172871735896.84M → PAEGF
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$22,913$1,947.19+$232854599801468864.00M → PAEGF
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$27,662$2,823.89+$310570858137017057280.00M → PAEGF
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$34,159$4,173.35+$3.871481543016132e+23M → PAEGF
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$43,337$6,308.80+$4.510617497632811e+26M → PAEGF
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$56,776$9,798.13+$4.911780474428384e+29M → PAEGF

PAEGF vs MRK: Complete Analysis 2026

PAEGF — Stock

Peace Arch Entertainment Group Inc. produces, acquires, and distributes feature films, television, and home entertainment content worldwide. It operates in three segments: Motion Picture, Television, and Home Entertainment. The Motion Picture segment produces feature films, which are intended for DVD or television premieres, as well as for worldwide theatrical release; licenses distribution rights of productions to sub-distributors; and distributes catalogues. The Television segment licenses television films, series of episodes, documentaries, and other programming to broadcasters, cable and satellite television providers, and home entertainment distributors. It also provides made-for-television movies and mini-series. The Home Entertainment segment distributes DVDs and ancillary merchandise to retailers in Canada and the United States. This segment also distributes sell-through and rental films of various genres, such as children's and family, special interest, and live action feature films. The company was formerly known as Vidatron Entertainment Group Inc. and changed its name to Peace Arch Entertainment Group Inc. in July 1999. Peace Arch Entertainment Group Inc. was founded in 1986 and is based in Toronto, Canada.

Full PAEGF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PAEGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAEGF vs SCHDPAEGF vs JEPIPAEGF vs OPAEGF vs KOPAEGF vs MAINPAEGF vs JNJPAEGF vs ABBVPAEGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.